Dong-Uk Kim

Dr. Dong-Uk Kim


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2015 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
JKJinsil Kim
Jinsil Kim
HHHye-Jeong Ha
Hye-Jeong Ha
SKSujin Kim
Sujin Kim
ACAh-Reum Choi
Ah-Reum Choi
SLSook-Jeong Lee
Sook-Jeong Lee
DKDong-Uk Kim
Dong-Uk Kim

1 July 2020 in Biomolecules & Therapeutics
Verified
Journal Article
Open access
ECEun Kyoung Choi
Eun Kyoung Choi
EPEun Jung Park
Eun Jung Park
TPTien Thuy Phan
Tien Thuy Phan
HKHea Dong Kim
Hea Dong Kim
KHKwang-Lae Hoe
Kwang-Lae Hoe
DKDong-Uk Kim
Dong-Uk Kim
Econazole, a potent broad-spectrum antifungal agent and a Ca2+ channel antagonist, induces cytotoxicity in leukemia cells and is used for the treatment of skin infections. However, little is known about its cytotoxic effects on solid tumor cells. Here, we investigated the molecular mechanism underlying econazole-induced toxicity in vitro and evaluated its regulatory effect on the metastasis of gastric cancer cells. Using the gastric cancer cell lines AGS and SNU1 expressing wild-type p53 we demonstrated that econazole could significantly reduce cell viability and colony-forming (tumorigenesis) ability. Econazole induced G0/G1 phase arrest, promoted apoptosis, and effectively blocked proliferation- and survival-related signal transduction pathways in gastric cancer cells. In addition, econazole inhibited the secretion of matrix metalloproteinase- 2 (MMP-2) and MMP-9, which degrade the extracellular matrix and basement membrane. Econazole also effectively inhibited the metastasis of gastric cancer cells, as confirmed from cell invasion and wound healing assays. The protein level of p53 was significantly elevated after econazole treatment of AGS and SNU1 cells. However, apoptosis was blocked in econazole-treated cells exposed to a p53-specific small-interfering RNA to eliminate p53 expression. These results provide evidence that econazole could be repurposed to induce gastric cancer cell death and inhibit cancer invasion.

14 February 2023 in Biomolecules & Therapeutics
Verified
Journal Article
Open access
PDF file
ECEun Kyoung Choi
Eun Kyoung Choi
HKHae Dong Kim
Hae Dong Kim
EPEun Jung Park
Eun Jung Park
SSSeuk Young Song
Seuk Young Song
TPTien Thuy Phan
Tien Thuy Phan
KHKwang-Lae Hoe
Kwang-Lae Hoe
Eun Kyoung Choi, Hae Dong Kim, Eun Jung Park, Seuk Young Song, Tien Thuy Phan, Miyoung Nam, Minjung Kim, Dong-Uk Kim and Kwang-Lae Hoe. Biomolecules & Therapeutics -0001;0:. https://doi.org/10.4062/biomolther.2023.004

19 January 2011 in BMC Genomics
Verified
Journal Article
Open access
PDF file
Laura GattiLaura Gatti
Laura Gatti
KHKwang-Lae Hoe
Kwang-Lae Hoe
JHJacqueline Hayles
Jacqueline Hayles
SRSabina C Righetti
Sabina C Righetti
NCNives Carenini
Nives Carenini
Paola PeregoPaola Perego
Paola Perego
Background: The ubiquitin(Ub)-proteasome pathway is implicated in the regulation of a variety of cellular functions and plays a major role in stress response in eukaryotic cells, by targeting misfolded and damaged proteins for degradation. In addition, in the presence of DNA damage, the Ub-proteasome system regulates proteins involved in sensing, repairing, and/or tolerating the damage. Antitumor agents such as cisplatin can activate the pathway, but the role of specific pathway components in cell sensitivity/response to the drug is not known. Since platinum compounds represent clinically relevant antitumor agents and a major limitation to their use is the development of drug resistance, there is an urgent need for identifying targets for improving their efficacy.Results: In the present study, we performed a genome-wide screening for sensitivity to cisplatin using non-essential haploid deletion mutants of the fission yeastSchizosaccharomyces pombe, belonging to a collection of haploid strains constructed through homologous recombination. Using this approach, we identified three Ub-proteasome mutants exhibiting hypersensitivity to cisplatin (ubp16,ubc13andpmt3) and ten mutants (includingufd2,beta7 20S,rpt6/let1) resistant to the drug. In addition, the importance of lub1 gene emerged from the comparison between the present screening and gene expression profile data previously obtained in fission yeast.Conclusions: The factors identified in the present study allowed us to highlight most finely the close relationship between the Ub-proteasome system and DNA damage response mechanisms, thus establishing a comprehensive framework of regulators likely relevant also in higher eukaryotes. Our results provide the proof of principle of the involvement of specific genes modulated by cisplatin treatment in cell response to the drug, suggesting their potential role as targets for modulating cisplatin sensitivity. In this regard, the prospective identification of novel targets for modulation of cisplatin sensitivity in an eukaryotic model organism appears particularly intriguing towards the discovery of strategies to overcome cisplatin resistance in human tumors.

14 October 2021 in Frontiers in Pharmacology
Verified
Journal Article
Open access
HKHae Dong Kim
Hae Dong Kim
EPEun Jung Park
Eun Jung Park
ECEun Kyoung Choi
Eun Kyoung Choi
SSSeuk Young Song
Seuk Young Song
KHKwang-Lae Hoe
Kwang-Lae Hoe
DKDong-Uk Kim
Dong-Uk Kim
G-749 is an FLT3 kinase inhibitor that was originally developed as a treatment for acute myeloid leukemia. Some FLT3 kinase inhibitors are dual kinase inhibitors that inhibit the TAM (Tyro3, Axl, Mer) receptor tyrosine kinase family and are used to treat solid cancers such as non-small cell lung cancer (NSCLC) and triple-negative breast cancer (TNBC). AXL promotes metastasis, suppression of immune response, and drug resistance in NSCLC and TNBC. G-749, a potential TAM receptor tyrosine kinase inhibitor, and its derivative SKI-G-801, effectively inhibits the phosphorylation of AXL at nanomolar concentration (IC50 = 20 nM). This study aimed to investigate the anticancer effects of G-749 targeting the TAM receptor tyrosine kinase in colon cancer. Here, we demonstrate the potential of G-749 to effectively inhibit tumorigenesis by degrading TYRO3 via regulated intramembrane proteolysis both in vitro and in vivo. In addition, we demonstrated that G-749 inhibits the signaling pathway associated with cell proliferation in colon cancer cell lines HCT15 and SW620, as well as tumor xenograft mouse models. We propose G-749 as a new therapeutic agent for the treatment of colon cancer caused by abnormal TYRO3 expression or activity.

1 November 2014 in Journal of Microbiological Methods
Verified
Journal Article
Closed access
MNMiyoung Nam
Miyoung Nam
SLSook-Jeong Lee
Sook-Jeong Lee
SHSangjo Han
Sangjo Han
DKDongsup Kim
Dongsup Kim
MLMinho Lee
Minho Lee
KHKwang-Lae Hoe
Kwang-Lae Hoe